Magic mushrooms are illegal under US federal controlled-substances law because 21 USC 812 lists psilocybin and psilocyn in Schedule I. 21 CFR 1308.11 repeats those listings. The 1971 Convention on Psychotropic Substances lists both substances separately.
Federal law applies in every state, and this page does not settle any individual or local case. The statutes, regulation and treaty text were read on November 15, 2026.
Why Are Magic Mushrooms Illegal in the US?
Under US federal law, the answer to why are magic mushrooms illegal begins with the substances named in Section 812(c). It lists psilocybin and psilocyn among Schedule I hallucinogenic substances. The statute names the substances rather than using the term "magic mushrooms." Schedule I(c) covers "any material, compound, mixture, or preparation, which contains any quantity of" the listed substances, which is the text that reaches a mushroom containing psilocybin or psilocyn.
The federal regulation repeats the listings. Its entry (29) assigns psilocybin Drug Enforcement Administration (DEA) code 7437. Entry (30) assigns psilocyn code 7438. Psilocin is a common alternative spelling.
Possession, manufacture and distribution of a controlled substance are federal offenses outside DEA-registered research, including Food and Drug Administration (FDA)-authorized trials conducted under 21 USC 823(n), and other settings the statute authorizes. 21 USC 841(a)(1) covers manufacture and distribution, and 21 USC 844(a) covers possession. Psilocybin and psilocyn are controlled substances because section 812(c) lists them.
A state program does not remove psilocybin or psilocyn from the federal schedules. Whether a separate state rule applies depends on the state, and no state program establishes legality in every reader's jurisdiction.
The Legal Chain at a Glance
| Legal basis | Citation | What it does | Source |
|---|---|---|---|
| Statute | 21 USC 812(b)(1), (c) | States the Schedule I criteria and lists psilocybin and psilocyn. | Statutory text |
| Regulation | 21 CFR 1308.11(d) | Repeats both substances in the federal Schedule I regulation. | Regulatory text |
| Enacting law | Public Law 91-513, § 202 (1970) | Placed both substances in the Act's original Schedule I list. | 1970 Act |
| Implementing act | Public Law 95-633 (1978) | Addressed US implementation of the psychotropic-substances treaty through domestic law. | 1978 Act |
| Treaty | 1971 Convention, Schedule I and Article 7 | Lists both substances and sets controls for treaty parties. | Convention text |
What Schedule I Requires
Section 812(b)(1) sets out three findings required for Schedule I placement. The first is "a high potential for abuse." In plain terms, Congress made abuse potential part of the legal classification test.
The second finding in Section 812(b)(1) is "no currently accepted medical use in treatment in the United States." The third is "a lack of accepted safety for use of the drug or other substance under medical supervision." These are the statute's criteria, rather than claims about an individual patient or a particular proposed treatment.
Section 812(c) lists psilocybin and psilocyn under those statutory criteria. The listing establishes their federal Schedule I status. The criteria explain what that classification requires. The statutory text cited here does not establish why individual lawmakers supported the original listing.
Congress's motives for naming these substances in 1970 are not reported in the saved sources. The statutory criteria should therefore not be presented as a record of each lawmaker's reasoning. The distinction matters when answering why shrooms are illegal: the cited law supplies the legal basis, while the saved sources do not supply a broader account of political motives.
How the 1970 Law Made Magic Mushrooms Illegal
Public Law 91-513, approved October 27, 1970, included psilocybin and psilocyn in its original Schedule I list. Section 202 placed them at entries (15) and (16) among hallucinogenic substances. The same entries appear in the current text of 21 USC 812(c).
The 1971 United Nations Convention on Psychotropic Substances supplies a separate international obligation. Its Schedule I names psilocine, also called psilotsin, and psilocybine. Article 7 requires treaty parties to prohibit use except for scientific and very limited medical purposes by duly authorized persons in specified establishments.
Article 7 also requires special licensing or prior authorization for manufacture, trade, distribution, and possession, along with close supervision. Those treaty requirements concern the obligations of parties to the Convention. They do not, by themselves, replace the cited US statute as the basis for the federal listing.
Congress addressed that distinction in the Psychotropic Substances Act of 1978, approved November 10, 1978. In 21 USC 801a, Congress said the Convention "is not self-executing" and requires appropriate legislation to perform US obligations. Congress also stated that controls should operate within the 1970 Act's classification procedures and criteria.
Can Federal Law on Magic Mushrooms Change?
Federal scheduling can change through the process in 21 USC 811 or through an act of Congress. Section 811(a) permits the Attorney General, by rule and upon the required findings, to add a substance, transfer it between schedules, or remove it. The rulemaking occurs on the record after an opportunity for a hearing.
Section 811(a) permits a proceeding to begin through the Attorney General, a request from the Secretary of Health and Human Services (HHS), or a petition from an interested party. Before starting a proceeding, Section 811(b) requires the Attorney General to request an HHS scientific and medical evaluation and recommendations. The statutory steps do not establish that a particular change will occur.
Section 811(j) contains a separate interim-rule provision for a drug referred to in Section 811(f) when its stated conditions are met. Nothing establishes that this provision automatically changes psilocybin's status. The COMP360 psilocybin application and its review status are covered in COMP360 FDA approval status. The Schedule I rescheduling process and psilocybin therapy status are separate questions.
A later Attorney General rule following the statutory process, or a new act of Congress, could change the federal answer. A date or outcome for either event is not reported in the saved sources. Until a change takes effect, the federal listings in Section 812 and 21 CFR 1308.11 remain the relevant citations.
Who Can Lawfully Handle Schedule I Psilocybin
21 USC 822(a)(1) requires a person who manufactures or distributes a controlled substance to obtain an annual registration from the Attorney General.
For practitioner research with Schedule I substances, 21 USC 823(g)(2)(A) requires referral of a registration application to HHS. HHS evaluates the practitioner's qualifications and the research protocol under that provision.
The Religious Freedom Restoration Act (RFRA) provides a way to assert a religious-exercise claim or defense. Under 42 USC 2000bb-1, a substantial burden is subject to the statute's compelling-interest and least-restrictive-means test. The provision does not itself announce a general exemption for mushroom use.
Religious-use claims are decided case by case. A general RFRA exemption covering mushroom use is not reported. That absence does not rule out a claim in a specific case. The separate account of RFRA and psychedelic religious exemptions addresses that legal framework.
What State Programs Do and Do Not Change
State programs described in the site's legal-status records do not change federal Schedule I status. The Oregon legal-status record describes Measure 109 psilocybin services at licensed service centers for clients aged 21 or older. It also records that federal Schedule I status continues to apply.
The Colorado legal-status record describes state-law decriminalization of personal psilocybin and psilocin use, possession, and gifting for adults aged 21 or older. It also describes licensed healing centers offering facilitated psilocybin sessions. Federal Schedule I status continues to apply, and the Colorado record says retail sale and distribution are not permitted under that state program.
Neither state record establishes that psychedelic mushrooms are legal everywhere in the United States. Washington's Schedule I statute separately lists psilocybin and psilocyn, illustrating why a state rule cannot be inferred from another state's program. The sources do not establish the law for every municipality or individual circumstance.
See the state-by-state mushroom legality guide. See also what psychedelics are legal in the US. Neither state program removes the federal psilocybin and psilocyn listings.
Federal Status and State-Specific Questions
For anyone asking about US federal law, magic mushrooms are illegal because the Controlled Substances Act names psilocybin and psilocyn in Schedule I. The federal regulation repeats the listings. The 1971 Convention adds treaty obligations, while 21 USC 801a says the treaty is not self-executing. Outside DEA-registered research, including FDA-authorized trials conducted under 21 USC 823(n), and other settings the statute authorizes, possession, manufacture and distribution remain federal offenses under 21 USC 841(a)(1) and 21 USC 844(a).
Federal law offers no route to obtain or use mushrooms outside the registered research settings above. It also cannot resolve state-specific or individual legal questions. A person with such a question should read the relevant state record and ask a licensed attorney.
An Attorney General rescheduling rule after an HHS evaluation or an act of Congress could change the general federal answer. A court-recognized RFRA exemption could change the answer for a specific claimant without changing the general listing. For a state-specific follow-up to "why are magic mushrooms illegal," check the state-by-state legal status tool for the relevant state.